Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Toevoeging van abirateron nuttig bij hoogvolume mCSPC
jun 2022 | Uro-oncologie